We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVTS icon
901
Navitas Semiconductor
NVTS
$2.78B
$6.08M 0.01%
1,274,766
+1,206,035
+1,755% +$7.08M
VYX icon
902
NCR Voyix
VYX
$1.13B
$6.07M 0.01%
+480,705
New +$6.92M
SMH icon
903
VanEck Semiconductor ETF
SMH
$66.1B
$6.06M 0.01%
+26,956
New +$5.42M
PPG icon
904
PPG Industries
PPG
$26.4B
$6.06M 0.01%
41,833
-87,249
-68% -$12.4M
EIX icon
905
Edison International
EIX
$30.3B
$6.04M 0.01%
+85,452
New +$5.84M
RNG icon
906
RingCentral
RNG
$4.5B
$6.04M 0.01%
173,773
+52,980
+44% +$1.78M
BTU icon
907
Peabody Energy
BTU
$2.81B
$6.03M 0.01%
248,632
-219,600
-47% -$5.53M
CCI icon
908
Crown Castle
CCI
$32.4B
$6.02M 0.01%
+56,900
New +$6.19M
FL
909
DELISTED
Foot Locker
FL
$6.02M 0.01%
211,111
-398,897
-65% -$11.5M
JACK icon
910
Jack in the Box
JACK
$299M
$5.97M 0.01%
87,173
+37,818
+77% +$2.85M
PETQ
911
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$5.95M 0.01%
325,587
-170,586
-34% -$3.04M
ESPR
912
DELISTED
Esperion Therapeutics
ESPR
$5.94M 0.01%
2,215,961
+1,758,203
+384% +$4.27M
HON icon
913
PUT
Honeywell
HON
$77.9B
$5.93M 0.01%
+30,981
New +$5.83M
AVY icon
914
Avery Dennison
AVY
$12.5B
$5.93M 0.01%
+26,561
New +$5.51M
FRO icon
915
Frontline
FRO
$8.59B
$5.92M 0.01%
253,243
-18,130
-7% -$409K
CRWD icon
916
PUT
CrowdStrike
CRWD
$183B
$5.9M 0.01%
+71,600
New +$5.48M
EEM icon
917
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$5.9M 0.01%
+137,000
New +$5.45M
PNR icon
918
Pentair
PNR
$10.2B
$5.89M 0.01%
68,964
+52,783
+326% +$4M
BF.B icon
919
Brown-Forman Class B
BF.B
$12.6B
$5.89M 0.01%
114,121
+11,024
+11% +$614K
EDIT icon
920
Editas Medicine
EDIT
$411M
$5.87M 0.01%
791,320
-319,882
-29% -$2.66M
BLK icon
921
CALL
Blackrock
BLK
$165B
$5.86M 0.01%
+7,300
New +$5.86M
ZGN icon
922
Zegna
ZGN
$4B
$5.85M 0.01%
399,303
+384,447
+2,588% +$4.97M
BBWI icon
923
Bath & Body Works
BBWI
$4.13B
$5.85M 0.01%
116,916
-35,935
-24% -$1.61M
GSL icon
924
Global Ship Lease
GSL
$1.55B
$5.78M 0.01%
284,561
+160,693
+130% +$3.27M
DBI icon
925
Designer Brands
DBI
$298M
$5.75M 0.01%
+525,883
New +$5.04M

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.